tiprankstipranks
Advertisement
Advertisement

ORKA Stock Latest News

Oruka Therapeutics: Buy Rating Reaffirmed as EVERLAST-A Data Support Once-Yearly ORKA-001; $120 Price Target Maintained
RatingsOruka Therapeutics: Buy Rating Reaffirmed as EVERLAST-A Data Support Once-Yearly ORKA-001; $120 Price Target Maintained
11h ago
ORKA
Oruka: Differentiated IL-23 Profile and Solid Cash Runway Support Maintained Buy Rating and Unchanged $125 Price Target
PremiumRatings
Oruka: Differentiated IL-23 Profile and Solid Cash Runway Support Maintained Buy Rating and Unchanged $125 Price Target
3d ago
ORKA
3 Healthcare Stocks with Strong Upside to Consider in July 2026, According to Analysts
PremiumMarket News
3 Healthcare Stocks with Strong Upside to Consider in July 2026, According to Analysts
1M ago
BSX
INSM
Oruka Therapeutics falls -8.1%
PremiumThe Fly
Oruka Therapeutics falls -8.1%
1M ago
ORKA
Oruka Therapeutics price target raised to $130 from $100 at UBS
PremiumThe Fly
Oruka Therapeutics price target raised to $130 from $100 at UBS
1M ago
ORKA
BTIG says others may be interested in Apogee Therapeutics
PremiumThe FlyBTIG says others may be interested in Apogee Therapeutics
1M ago
JNJ
NVS
Oruka Therapeutics Shareholders Back Governance and Executive Pay
Premium
Company Announcements
Oruka Therapeutics Shareholders Back Governance and Executive Pay
2M ago
8K
ORKA
Kapoor Reiterates Buy on Oruka Therapeutics as Pipeline Advances; Keeps $120 Price Target Unchanged
Premium
Ratings
Kapoor Reiterates Buy on Oruka Therapeutics as Pipeline Advances; Keeps $120 Price Target Unchanged
2M ago
ORKA
Oruka Therapeutics Expands IL-23 License, Adds Dosing Limits
PremiumCompany Announcements
Oruka Therapeutics Expands IL-23 License, Adds Dosing Limits
2M ago
8K
ORKA
Oruka: Strong ORKA-001 Clinical Profile and Pipeline Momentum Support Reiterated Buy Rating and Unchanged $120 Price Target
PremiumRatings
Oruka: Strong ORKA-001 Clinical Profile and Pipeline Momentum Support Reiterated Buy Rating and Unchanged $120 Price Target
3M ago
ORKA
Julian Harrison Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target on Strong Clinical Profile and Cash Position
PremiumRatings
Julian Harrison Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target on Strong Clinical Profile and Cash Position
3M ago
ORKA
Oruka Initiated With Buy on Best-in-Class ORKA-001 Psoriasis Data, Strong Cash Position, and Multi-Billion-Dollar Upside Potential
PremiumRatings
Oruka Initiated With Buy on Best-in-Class ORKA-001 Psoriasis Data, Strong Cash Position, and Multi-Billion-Dollar Upside Potential
3M ago
ORKA
Oruka Therapeutics reports Q1 EPS (48c), consensus (54c)
PremiumThe FlyOruka Therapeutics reports Q1 EPS (48c), consensus (54c)
3M ago
ORKA
Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis
Premium
The Fly
Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis
3M ago
HALO
ORKA
Oruka Therapeutics Completes Public Equity Offering Under Shelf
Premium
Company Announcements
Oruka Therapeutics Completes Public Equity Offering Under Shelf
3M ago
8K
ORKA
Oruka Therapeutics price target raised to $120 from $109 at Leerink
PremiumThe Fly
Oruka Therapeutics price target raised to $120 from $109 at Leerink
3M ago
ORKA
Oruka Therapeutics price target raised to $120 from $75 at H.C. Wainwright
PremiumThe Fly
Oruka Therapeutics price target raised to $120 from $75 at H.C. Wainwright
3M ago
ORKA
Oruka Therapeutics $700M Secondary priced at $72.50
PremiumThe Fly
Oruka Therapeutics $700M Secondary priced at $72.50
3M ago
ORKA
Oruka Therapeutics price target raised to $100 from $75 at UBS
PremiumThe Fly
Oruka Therapeutics price target raised to $100 from $75 at UBS
3M ago
ORKA
Oruka Therapeutics announces $500M common stock, warrants offering
PremiumThe FlyOruka Therapeutics announces $500M common stock, warrants offering
3M ago
ORKA
Oruka Therapeutics price target raised to $131 from $71 at Clear Street
Premium
The Fly
Oruka Therapeutics price target raised to $131 from $71 at Clear Street
3M ago
ORKA
Morning News Wrap-Up, 4/27/26: Today’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up, 4/27/26: Today’s Biggest Stock Market Stories!
3M ago
AMD
DIA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >